News
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the ...
Kenvue says that Thibaut Mongon is leaving as CEO as the maker of Listerine and Band-Aid brands continues with a strategic ...
American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...
Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO ...
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Explore more
Kenvue Inc. (NYSE: KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s ...
6d
Barchart on MSNTylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?Kenvue Inc ousted its chief executive and announced a strategic review on Monday. Jefferies says KVUE shares could rally to ...
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
Kenvue Inc. closed 13.19% below its 52-week high of $25.17, which the company achieved on May 8th.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results